EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

Management of hereditary angioedema in the UK: a comparison with international guidelines

Patrick F K Yong, Jolanta Bernatoniene, Rachel Annals, Charu Chopra, Tanya Coulter, Sarah Denman, Anthony Dorr, Tariq El-Shanawany, Alexandros Grammatikos, Padmalal Gurugama, Rashmi Jain, Sorena Kiani-Alikhan, Lucy Leeman, Lorena Lorenzo, Ania Manson, Sadia Noorani, Smita Patel, Arthur Price, Ravi Sargur, Cathal Steele, Catherine Stroud, Cassim Akhoon, Ariharan Anantharachagan, Emily Carne, Samuel Chee, Joanne Miller, Stephen Owens, Christine Symons, Ky-Lyn Tan, Michael D Tarzi, Scott Hackett, Angela Metcalfe, Sinisa Savic, Tomaz Garcez

Clinical and Experimental Immunology · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Abstract Hereditary angioedema (HAE) is a rare genetic disorder characterised by recurrent episodes of swelling, which can potentially be life-threatening, resulting in substantial physical, psychological, educational and occupational burden. Treatment of HAE is divided into on-demand treatment for acute attacks and long-term prophylaxis for prevention of attacks, and there are now several effective therapies available. However, in the UK, use of on-demand therapy is intended for attacks defined as clinically significant, and access to long-term prophylaxis is determined primarily by frequency-based criteria. In this policy-focused review, we compare UK access criteria with international guidelines on best practice. We conclude that UK access criteria result in a group of HAE patients with persisting unmet need, and this may have a greater impact in children and young people. In view of this, we recommend greater flexibility in access criteria, allowing clinical judgement, shared decision-making, and broader measures of disease burden to inform treatment eligibility, so we can individualise care and fully meet the needs of these patients.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Patrick F K Yong, Jolanta Bernatoniene, Rachel Annals, Charu Chopra, Tanya Coulter, Sarah Denman, Anthony Dorr, Tariq El-Shanawany, Alexandros Grammatikos, Padmalal Gurugama, Rashmi Jain, Sorena Kiani-Alikhan, Lucy Leeman, Lorena Lorenzo, Ania Manson, Sadia Noorani, Smita Patel, Arthur Price, Ravi Sargur, Cathal Steele, Catherine Stroud, Cassim Akhoon, Ariharan Anantharachagan, Emily Carne, Samuel Chee, Joanne Miller, Stephen Owens, Christine Symons, Ky-Lyn Tan, Michael D Tarzi, Scott Hackett, Angela Metcalfe, Sinisa Savic, Tomaz Garcez
Quelle
Clinical and Experimental Immunology
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
0009-9104, 1365-2249
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Patrick F K Yong, Jolanta Bernatoniene, Rachel Annals, Charu Chopra, Tanya Coulter, Sarah Denman, Anthony Dorr, Tariq El-Shanawany, Alexandros Grammatikos, Padmalal Gurugama, Rashmi Jain, Sorena Kiani-Alikhan, Lucy Leeman, Lorena Lorenzo, Ania Manson, Sadia Noorani, Smita Patel, Arthur Price, Ravi Sargur, Cathal Steele, Catherine Stroud, Cassim Akhoon, Ariharan Anantharachagan, Emily Carne, Samuel Chee, Joanne Miller, Stephen Owens, Christine Symons, Ky-Lyn Tan, Michael D Tarzi, Scott Hackett, Angela Metcalfe, Sinisa Savic, Tomaz Garcez (2026). Management of hereditary angioedema in the UK: a comparison with international guidelines. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxag056
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1